Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

88.85 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
72 73 Next >
News headline image
US Supports Delay On COVID Patent Waiver Extension Decision ↗
Developing countries have been pushing for a patent waiver extension for COVID-19, which many developed countries argue could discourage pharma companies from responding rapidly to future global health... 
Via Benzinga
News headline image
UK's Regulatory Agency Backs Pfizer/BioNTech's COVID-19 Vaccine For Youngest Kids ↗
 
Via Benzinga
News headline image
Pfizer, BioNTech Fire Back At Moderna Over COVID-19 Vaccine Related Patent Claims ↗
 
Via Benzinga
News headline image
BioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzinga's Most Accurate Analysts ↗
Although US stocks closed mixed on Thursday, but healthcare stocks recorded gains, gaining over 0.2% in the previous session. Biotechnology stocks were among the top performers in the sector, adding... 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
BioNTech, Ryvu Therapeutics Join Forces For Immuno-Modulatory Candidates ↗
 
Via Benzinga
News headline image
BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates
From BioNTech SE
Via GlobeNewswire
News headline image
2 Biotech Stocks You Can Buy and Hold for the Next Decade ↗
These two companies are facing short-term issues that are likely to give way to long-term success. 
Via The Motley Fool
News headline image
Is Novavax Stock a Buy Now? ↗
There's probably not much good news coming for this biotech in the near future. 
Via The Motley Fool
News headline image
European Official Says COVID-19 Booster Uptake Disappointing In The Region ↗
Marco Cavaleri, the European Medicines Agency's (EMA) head of health threats and vaccines strategy, said the recent uptake of COVID-19 vaccine booster doses in the region has been "rather... 
Via Benzinga
News headline image
Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains ↗
Researchers are working on an experimental pan-influenza vaccine based on the famed mRNA technology to provide broad protection. 
Via Benzinga
News headline image
Is Now the Time for Income Investors to Buy This Big Pharma Stock? ↗
This drugmaker is among the most dominant pharmaceutical companies in the world. 
Via The Motley Fool
News headline image
7 Stocks on the Perfect 10 List ↗
Companies that have strong quality, value, or growth grades are the stocks to buy once markets recognize their business potential. 
Via InvestorPlace
News headline image
PFE Stock Could Be the Booster Shot Your Portfolio Needs Now ↗
PFE stock still remains a dirt-cheap dividend darling, even after across-the-board earnings beats and lifted guidance. 
Via InvestorPlace
News headline image
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It ↗
COVID-19 cases have spiked again in China, sparking fresh lockdown measures in the nation's capital. Jim Cramer has suggested that Chinese President Xi Jinping isn't telling the whole story.  
Via Benzinga
News headline image
2 Reasons to Buy Pfizer and 1 Reason to Sell ↗
The pharmaceutical company is looking for a future beyond COVID-19 therapies. 
Via The Motley Fool
News headline image
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade ↗
Bill Gates has two portfolios he makes trades from: the Bill & Melinda Gates Foundation and the Bill & Melinda Gates Foundation Trust. 
Via Benzinga
News headline image
7 Stocks to Sell Right Now… and 1 to Buy ↗
Although red ink can sometimes bring an opportunity for contrarianism, these (except one) market ideas represent stocks to sell. 
Via InvestorPlace
News headline image
Pfizer/BioNTech's Omicron Tailored COVID-19 Vaccine Shows Improved Immune Response Against Emerging Omicron Sublineages ↗
 
Via Benzinga
News headline image
Market Rally Holds Key Levels, But Breakouts Struggle; Walmart, Target, Nvidia In Focus: Weekly Review ↗
Walmart, Target and Nvidia were key earnings movers. 
Via Investor's Business Daily
News headline image
Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Improved Immune Response Against Emerging Omicron Sublineages
From BioNTech SE
Via GlobeNewswire
News headline image
Pfizer, BioNTech Take Next Step Toward A Pan-Covid Vaccine — But Is The Demand There? ↗
The biggest question facing the shot is whether there will be demand for it. 
Via Investor's Business Daily
News headline image
Ukraine Asserts It Does Not Take Blame For Poland Missile Attack, Crypto Exchange Gemini Suffers $485M In Outflows, FTX, Bahamas Regulator Lock Horns Over Control Of Bankruptcy Proceedings: Top Stories Thursday, Nov. 17 ↗
CNBC 
Via Benzinga
News headline image
Pfizer, BioNTech Start Work On Next-Gen COVID-19 Vaccine Candidate For Broader Protection ↗
 
Via Benzinga
News headline image
Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection
From BioNTech SE
Via GlobeNewswire
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say ↗
Australian health authorities have recommended against a fifth COVID-19 vaccine shot despite average daily cases having been 47% higher last week than the week before, said Health Minister Mark Butler... 
Via Benzinga
News headline image
Moderna Surges On New Omicron Data, Pulling Pfizer, BioNTech Along For The Ride ↗
Its booster led to a 15.1-fold increase in BA.4- and BA.5-blocking antibodies. 
Via Investor's Business Daily
Biotech Sector Gaining Wins Against Pancreatic Cancer with Early Detection and New Therapies
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 14, 2022 – USA News Group – English actor, comedian and Monty Python alumnus Eric Idle credits early detection for his... 
Via FinancialNewsMedia
News headline image
BioNTech Plans To Set Up Singapore Based mRNA Plant By End Of 2023 ↗
 
Via Benzinga
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
72 73 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.